{"text": "Thus, FGF6 is increased in PIN and prostate cancer and can promote the proliferation of the transformed prostatic epithelial cells via paracrine and autocrine mechanisms.", "id": "10945637.s12", "metadata": {"CCS": "normalTOcancer", "CGE": "increased", "IGE": "unchanged", "PT": "causality", "cancer_type": "prostate", "expression_change_keyword_1": {"name": "\nNone\n", "pos": null, "type": null}, "expression_change_keyword_2": {"name": "increased", "pos": [14, 22], "type": "Positive_regulation"}}, "labeled_spans": {"annotations": [{"start": 6, "end": 10, "label": "GENE", "score": 1.0, "_id": -4685428526827816387}, {"start": 35, "end": 50, "label": "CANCER", "score": 1.0, "_id": -611854743241672378}], "predictions": []}, "binary_relations": {"annotations": [{"head": -4685428526827816387, "tail": -611854743241672378, "label": "oncogene", "score": 1.0, "_id": -1790325547764256303}], "predictions": []}}
{"text": "Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.", "id": "11722842.s0", "metadata": {"CCS": "normalTOcancer", "CGE": "increased", "IGE": "unchanged", "PT": "observation", "cancer_type": "prostate", "expression_change_keyword_1": {"name": "over-expression", "pos": [99, 113], "type": "Gene_expression"}, "expression_change_keyword_2": {"name": "over-expression", "pos": [99, 113], "type": "Positive_regulation"}}, "labeled_spans": {"annotations": [{"start": 93, "end": 98, "label": "GENE", "score": 1.0, "_id": -2017777239235151954}, {"start": 118, "end": 133, "label": "CANCER", "score": 1.0, "_id": 4129617449961559606}], "predictions": []}, "binary_relations": {"annotations": [{"head": -2017777239235151954, "tail": 4129617449961559606, "label": "biomarker", "score": 1.0, "_id": 7993340717186791454}], "predictions": []}}
{"text": "We therefore conclude that MUC18 expression is increased during prostate cancer initiation (high grade PIN) and progression to carcinoma, and in metastatic cell lines and metastatic carcinoma.", "id": "11722842.s13", "metadata": {"CCS": "normalTOcancer", "CGE": "increased", "IGE": "unchanged", "PT": "observation", "cancer_type": "prostate", "expression_change_keyword_1": {"name": "expression", "pos": [33, 42], "type": "Gene_expression"}, "expression_change_keyword_2": {"name": "increased", "pos": [47, 55], "type": "Positive_regulation"}}, "labeled_spans": {"annotations": [{"start": 27, "end": 32, "label": "GENE", "score": 1.0, "_id": 5431679980839797458}, {"start": 64, "end": 79, "label": "CANCER", "score": 1.0, "_id": 1650882012654160466}], "predictions": []}, "binary_relations": {"annotations": [{"head": 5431679980839797458, "tail": 1650882012654160466, "label": "biomarker", "score": 1.0, "_id": -6073164971037079930}], "predictions": []}}
